NEUP
Neuphoria Therapeutics Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$3.77
+0.13%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.66x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.00x
- Net debt / EBITDA
- 0.85x
Liquidity & coverage
- Current ratio
- 14.31x
- Quick ratio
- 14.31x
- Cash ratio
- 12.85x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $20.1M
Cash & dividend
- FCF / debt
- 1737.45x
- Cash flow / debt
- 1737.45x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026